Vimarsana
Biggest News Aggregation in the World

Page 18 - Vascular Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vascular Access Today - Breaking & Trending Today

ivWatch Extends Its Global Reach Signing Three New Distribution Partners - Vimarsana News

ivWatch Extends Its Global Reach Signing Three New Distribution Partners

/PRNewswire/ -- Today, ivWatch, LLC, an innovative IV safety company working to eliminate harm caused by infiltration and extravasation events, announced three...

High Aldosterone Levels Increase Risk for CKD Progression - Vimarsana News

High Aldosterone Levels Increase Risk for CKD Progression

Higher serum aldosterone levels in patients with CKD increase the risk for CKD progression and end-stage kidney disease regardless of patient's diabetes status

Liability for Gender Transition; Dialysis Fraud; Abortion Support - Vimarsana News

Liability for Gender Transition; Dialysis Fraud; Abortion Support

The top 3 things you should know to start your day.

B. Braun Launches Introcan Safety® 2 IV Catheter with One-time Blood Control Designed to Make IV Access Safer for Clinicians - Vimarsana News

B. Braun Launches Introcan Safety® 2 IV Catheter with One-time Blood Control Designed to Make IV Access Safer for Clinicians

/PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in infusion therapy, announced today the launch of its new Introcan Safety 2 IV Catheter with...

Flat Medical Enters the Vascular Access Medtech Domain with its Newly Acquired MDR Certification and New Medical Advisor - Vimarsana News

Flat Medical Enters the Vascular Access Medtech Domain with its Newly Acquired MDR Certification and New Medical Advisor

/PRNewswire/ -- Flat Medical Co., Ltd., a MedTech company specializing in safety solutions for anesthesia and critical care procedures, announced that it has...